Profile

Fraunhofer Institute for Biomedical Engineering

Sight of Fraunhofer IBMT in Sulzbach
© Fraunhofer IBMT (Photo: Bernd Müller)

About Us

The Fraunhofer Institute for Biomedical Engineering (IBMT) is one of the six institutes of the Alliance Life Science of the Fraunhofer-Gesellschaft and concentrates mainly on manufacturing of devices and development of technology, well balanced between basic and applied research. IBMT is working in close collaboration with industry since its foundation in 1987. IBMT offers solutions in the areas of biomedical and medical engineering, biotechnology, cryotechnology, health telematics, laser medicine, environmental control systems, laboratory development, material testing, home systems, air quality control in homes and cars, security systems as well as industrial process automation and inline/online process control, in particular for food, chemical and pharmaceutical industry.

The institute promotes the "lively-experienced" technology transfer to medicine and biotechnology and various areas of industry and knowledge intense services. IBMT applies its potential on subjects such as: non- or minimal-invasivity, microsystems engineering, implant technology (interfaces between technical and biological microsystems), biohybrid systems, molecular bioanalytics, neuroprosthetics, molecular and cellular biotechnology, nano(bio)technology, biobanks, cryo(bio)technology, biocompatibility, ultrasound technology, sensor manufacturing technology, magnetic resonance, telemetrical data and energy transfer, health telematics and multilocal sensor systems connected by communication technologies as well as autonomous deep sea systems. It focuses on applications in the areas of medical diagnosis, therapy and therapy control as well as on equivalent needs in various industries. Important new fields are the methods and technologies for industrial applications of the molecular and cellular biotechnology and the cryotechnology for storage of living samples at low temperatures as well as isolation, cultivation and differentiation of stem cells for regenerative medicine. Since nearly 10 years Fraunhofer IBMT works in the field of stem cell research and obtained as the only institute of the Fraunhofer-Gesellschaft permissions (No. 18, 19 and 44) of the Robert-Koch-Institute to import and scientifically use human embryonal stem cells.

Technology transfer starting from basic research spans the whole innovation chain ranging from scientific-technical consulting, feasibility studies, prototype development, field tests, engineering and support to low- and medium-volume manufacturing is separate project phases. Spin-off companies of IBMT serve for system manufacturing when needed. IBMT is active in the regions Saarland State and Brandenburg State as well as Northrhine-Westfalia since beginning of 2012, and fulfills overhead-tasks in these regions with regard to regional restructuring. It acquires it´s projects worldwide.

With the foundation of IBMT, Fraunhofer Society intended to contribute to science and research in particular to modern technologies and technology transfer in the area of clinical research in cooperation with well-known national and international university departments and hospitals in various fields. IBMT is located in St. Ingbert with its mother institute (near Saarbrücken) and since April 2001 is directed by Prof. Dr. Günter Fuhr who also accepted a call on the Chair of Biotechnology and Medical Engineering.

The institute is financed by R&D contracts of public and private (industrial) customers. The integration of medical/biomedical, microsystems engineering and biotechnology at IBMT has leading opportunity in Europe. IBMT belongs to the network of the 66 independent institutes of the Fraunhofer Society. About 426 employees belonged to IBMT in 2013.

Scientific-technical know-how, and a long-term experience based on practical results and products in the areas of medical engineering, molecular and cellular biotechnology and microsystems engineering guarantees a high-level quality of R&D support and a flexible and adaptive definition of customer-tailored and problem-oriented task solutions.

Since September 2001 IBMT is a member of the Fraunhofer Alliance "Life Sciences".